455 On Other Exchanges
Symbol
Exchange
455 is not on other exchanges.

tianda pharmaceuticals ltd (455) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)
\

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. Its product range includes Chinese and western medicines and biochemical drugs, etc., such as cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, detoxification agents, and other pharmaceutical products; health care products comprising bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women’s nutrition, wellbeing, personal care, and honey products; and others. The company offers its health care products under the Herb Valley brand name. It also engages in property holding business. Tianda Pharmaceuticals Limited primarily operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

422 Employees
Last Reported Date: 12/21/17

tianda pharmaceuticals ltd (455) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianda pharmaceuticals ltd
Tianda Pharmaceuticals Limited Announces the Resignation of SHI Shaobin as Non-Executive Director, Effective from December 31, 2017

The board of directors of Tianda Pharmaceuticals Limited announced that Mr. SHI Shaobin (Mr. SHI) resigned as a non-executive director of the company with effect from December 31, 2017 in order to devote more time on his personal matters.

Tianda Pharmaceuticals Limited Appoints LAM Lee G. as Non-Executive Director, Effective on January 1, 2018

Tianda Pharmaceuticals Limited announced that Dr. LAM Lee G. (Dr. Lam) has been appointed as a non-executive director (NED) of the company with effect from January 1, 2018. Dr. Lam is Chairman of Hong Kong Cyberport Management Company Limited, and Non-Executive Chairman - Hong Kong and ASEAN Region and the Chief Adviser of Macquarie Infrastructure and Real Assets Asia.

Tianda Pharmaceuticals Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2017

Tianda Pharmaceuticals Limited announced unaudited consolidated earnings results for the six months ended September 30, 2017. For the six months period, the company reported revenue of HKD 126,498,062 against HKD 93,853,493 a year ago. Profit before tax was HKD 13,154,622 against HKD 20,715,499 a year ago. Profit for the period was HKD 9,843,005 against HKD 16,693,365 a year ago. Profit attributable to owners of the parent was HKD 2,636,232 against HKD 11,525,520 a year ago. Basic and diluted earnings per share were 0.12 cents against 0.54 cents a year ago. During the period, the group acquired items of property, plant and equipment of HKD 3,865,337 compared with HKD 1,354,709 for the six months ended 30 September 2016. During the reporting period, the group improved its sales performance by vigorously developing the third terminal sales channel to increase its customer base.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies
 

Industry Analysis

455

Industry Average

Valuation 455 Industry Range
Price/Earnings 100.0x
Price/Sales 2.9x
Price/Book 0.8x
Price/Cash Flow 183.9x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TIANDA PHARMACEUTICALS LTD, please visit www.tiandapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.